Inventor · disambiguated record
Shuhei Ikeda
Also filed as: IKEDA SHUHEI
13 granted patents·5 pending applications·54 citations·filing 2013–2024
89Inventor score
Top patents by PatentIndex Score
18 records- 0193US10610520B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Apr 7, 2020·9 cites·12 claims
- 0293US10323026B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 18, 2019·20 cites·10 claims
- 0388US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 0486US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 0583US9643957B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted May 9, 2017·6 cites·12 claims
- 0680US11827601B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Nov 28, 2023·0 cites·8 claims
- 0780US11274101B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 0878US11834409B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 5, 2023·0 cites·22 claims
- 0978US9598398B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 21, 2017·4 cites·14 claims
- 1076US9624170B24-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·3 cites·16 claims
- 1172US10112956B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 30, 2018·1 cites·11 claims
- 1266US9963443B2Radiolabeled compoundsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 8, 2018·1 cites·20 claims
- 1364US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1463US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1555US2025250230A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1652US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 1744US2016159808A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 1843US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shuhei Ikeda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →